Skip to main content
AMRX
NASDAQ Life Sciences

Amneal Launches Generic Lanreotide After FDA Approval, Targeting $983M Market

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$18.71
Mkt Cap
$5.975B
52W Low
$9.49
52W High
$19.26
52W Position info
97% above low
Off High info
2.9% below high
Rel. Volume info
2.6× avg
Market data snapshot near publication time

AMRX sits 97% above its 52-week low of $9.49 on elevated volume (2.6× avg).

Summary

Amneal received FDA approval for its lanreotide injection, a generic version of Ipsen's Somatuline Depot, and is launching immediately. The product targets a U.S. market with $983 million in annual sales, and Amneal secured Competitive Generic Therapy designation, which can provide 180 days of exclusivity. This is a material addition to the Affordable Medicines segment and follows the company's raised 2026 guidance and recent Kashiv BioSciences acquisition. The launch adds a high-value complex injectable to the portfolio, with in-house manufacturing supporting supply. Watch for initial prescription uptake and any commentary on the next earnings call regarding revenue contribution.

At the time of this announcement, AMRX was trading at $18.71 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $6B. The 52-week trading range was $9.49 to $19.26. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

AMRX - Latest Insights

AMRX
Nov 17, 2026, 4:05 PM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $21.12
Real-time Price: $21.50 info
Change: +$0.3775 (+2%) info
Market Cap: $7.487B info
AMRX
Nov 09, 2026, 4:21 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $21.28
Real-time Price: $21.50 info
Change: +$0.2175 (+1%) info
Market Cap: $7.487B info
AMRX
Nov 03, 2026, 6:00 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $20.23
Real-time Price: $21.50 info
Change: +$1.27 (+6%) info
Market Cap: $7.487B info
AMRX
Nov 03, 2026, 6:00 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $20.20
Real-time Price: $21.50 info
Change: +$1.30 (+6%) info
Market Cap: $7.487B info
AMRX
Oct 23, 2026, 4:05 PM EDT
Filing Type: 8-K/A
Importance Score:
8
Price at Filing: $20.38
Real-time Price: $21.50 info
Change: +$1.12 (+5%) info
Market Cap: $7.487B info